Trends in otitis media treatment failure and relapse
- PMID: 18381530
- DOI: 10.1542/peds.2007-1565
Trends in otitis media treatment failure and relapse
Abstract
Objectives: The goals were to describe trends in acute otitis media, treatment failure, and relapse and in high-dose amoxicillin use and to determine whether treatment of acute otitis media with high-dose amoxicillin was associated with treatment failure or relapse.
Methods: We conducted a retrospective study of acute otitis media visits made between 1996 and 2004 by children 2 months to 12 years of age in a large group practice, using computerized data. We defined acute otitis media as an otitis media visit with antibiotics dispensed (preceded by 30 days without otitis media visits), treatment failure as initiation of treatment with a second antibiotic before the first prescription was finished, and relapse as initiation of antibiotic treatment after the first prescription was finished but within 30 days after the index acute otitis media episode. The primary independent measure was high-dose amoxicillin (>70 mg/kg per day). We evaluated changes over time and determined whether high-dose amoxicillin use was associated with otitis media treatment failure or relapse.
Results: We identified 111,335 acute otitis media visits over a 9-year period. The incidence of acute otitis media decreased from 385.1 visits per 1000 enrollees in 1996 to 188.8 visits per 1000 enrollees in 2004. The proportion of acute otitis media visits treated with high-dose amoxicillin increased from 1.7% in 1996 to 41.9% in 2004. Both otitis media treatment failure and relapse rates decreased from 1996 to 2004 (from 3.9% to 2.6% and from 9.2% to 8.9%, respectively). The odds of treatment failure or relapse did not differ between acute otitis media episodes treated with high-dose and low-dose amoxicillin.
Conclusions: During the past decade, acute otitis media, treatment failure, and relapse became less common and high-dose amoxicillin use increased. However, high-dose amoxicillin treatment did not reduce the risk of individual infections resulting in adverse outcomes.
Similar articles
-
Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children.Pediatr Infect Dis J. 2003 May;22(5):405-13. doi: 10.1097/01.inf.0000065688.21336.fa. Pediatr Infect Dis J. 2003. PMID: 12792379
-
Treatment of recurrent otitis media after a previous treatment failure. Which antibiotics work best?J Fam Pract. 1999 Jan;48(1):43-6. J Fam Pract. 1999. PMID: 9934382
-
Single-dose intramuscular ceftriaxone for acute otitis media in children.Pediatrics. 1993 Jan;91(1):23-30. Pediatrics. 1993. PMID: 8416502 Clinical Trial.
-
Otitis media. A scholarly review of the evidence.Minerva Pediatr. 2003 Oct;55(5):407-14. Minerva Pediatr. 2003. PMID: 14608264 Review.
-
Valuing reduced antibiotic use for pediatric acute otitis media.Pediatrics. 2008 Apr;121(4):669-73. doi: 10.1542/peds.2007-1914. Pediatrics. 2008. PMID: 18381529 Review.
Cited by
-
Oral and middle ear delivery of otitis media standard of care antibiotics, but not biofilm-targeted antibodies, alter chinchilla nasopharyngeal and fecal microbiomes.NPJ Biofilms Microbiomes. 2024 Feb 3;10(1):10. doi: 10.1038/s41522-024-00481-0. NPJ Biofilms Microbiomes. 2024. PMID: 38310144 Free PMC article.
-
Pneumococcal conjugate vaccines for preventing acute otitis media in children.Cochrane Database Syst Rev. 2020 Nov 24;11(11):CD001480. doi: 10.1002/14651858.CD001480.pub6. Cochrane Database Syst Rev. 2020. PMID: 33231293 Free PMC article.
-
Pneumococcal conjugate vaccines for preventing acute otitis media in children.Cochrane Database Syst Rev. 2019 May 28;5(5):CD001480. doi: 10.1002/14651858.CD001480.pub5. Cochrane Database Syst Rev. 2019. Update in: Cochrane Database Syst Rev. 2020 Nov 24;11:CD001480. doi: 10.1002/14651858.CD001480.pub6. PMID: 31135969 Free PMC article. Updated.
-
Outpatient antibiotic use in Dutch infants after 10-valent pneumococcal vaccine introduction: a time-series analysis.BMJ Open. 2018 Jun 30;8(6):e020619. doi: 10.1136/bmjopen-2017-020619. BMJ Open. 2018. PMID: 29961011 Free PMC article.
-
Resistance of non-typeable Haemophilus influenzae biofilms is independent of biofilm size.Pathog Dis. 2017 Feb;75(1):ftw112. doi: 10.1093/femspd/ftw112. Epub 2016 Dec 11. Pathog Dis. 2017. PMID: 27956464 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
